A prediabetic phenotype of glucose intolerance, insulin resistance and obesity was observed at w12 months of age in mice homozygous for a null allele of the major skeletal muscle glycogen-targeting subunit G M of protein phosphatase 1 (PP1) and derived from a 129/Ola donor strain. In this study, backcrossing of these G 
Introduction
One of the problems in understanding type 2 diabetes is that multiple genes as well as environmental factors contribute to this disorder. In addition, current evidence indicates heterogeneity in the underlying genetic defects (Hansen & Pedersen 2005 , O'Rahilly et al. 2005 . A feature commonly observed in type 2 diabetes is that insulin-stimulated glycogen synthesis is decreased in skeletal muscle (Shulman 2000) . In this tissue, insulin stimulates glycogen synthesis via the translocation of the glucose transporter (GLUT4) and activation of glycogen synthase (GS; DeFronzo 1997, Shepherd & Kahn 1999) . Phosphorylation of GS by GS kinase-3 (GSK3) at sites 3a, b and c (now known to be Ser640, Ser644 and Ser648) leads to its inactivation, while dephosphorylation of these sites and activation of GS are catalysed by glycogen-bound protein phosphatase 1 (PP1) that is predominantly bound to the glycogen-targeting subunit G M /R GL (encoded by the gene PPP1R3A) in skeletal muscle (Cohen 1999) . Glycogen breakdown is catalysed by phosphorylase kinase and phosphorylase and the latter had been shown to be dephosphorylated with inactivation by PP1-G M in vivo (Toole & Cohen 2007) . Variations in PPP1R3A, the gene-encoding G M , have been noted in human populations and associated with diabetes in some populations but not others. For example, a five bp deletion mutation leading to decreased stability of G M mRNA was associated with diabetes in the Pima Indian population (Xia et al. 1998) . In addition, the same mutation was found at higher frequencies in males diagnosed early with type 2 diabetes in a Scottish population (Doney et al. 2003) . Individuals with severe insulin resistance within one family were identified as the only family members who were doubly heterozygous with respect to frameshift/premature stop mutations in the PPP1R3A and peroxisome proliferator-activated receptor g genes (Savage et al. 2002) .
In order to determine the physiological role of G M , two murine models homozygous for a null allele of G M have been generated in C57/BL6 backgrounds using donor cells from different substrains, 129/SvJ (Suzuki et al. 2001) and 129/Ola (Delibegovic et al. 2003) . In both models, glycogen levels in skeletal muscle of G
Materials and methods

Generation of G M -deficient ðG
K=K
M Þ mice
All animal procedures were approved by the University of Dundee Ethical Committee and were performed under a UK Home Office Project Licence. Mice heterozygous for a null allele of G M (Delibegovic et al. 2003) were backcrossed to either C57BL/6 or 129s2/sV for at least six generations, before heterozygotes were intercrossed to produce mice homozygous for the null allele ðG K=K M Þ, heterozygous, and homozygous for the wild-type allele ðG C=C M Þ, which were used in the analyses described herein. All mice were maintained in temperature-and humiditycontrolled conditions with a 12 h light:12 h darkness cycle and were allowed access to food and water ad libitum unless otherwise stated. Animals were fed either standard chow (nitrogen-free extract (NFE) 62%), a low-carbohydrate diet (NFE 51%) or a diet containing 30% extra glucose (NFE 72%) all from Special Diet Services (Witham, Essex, UK). NFE is a measure of 'usable' carbohydrate content of a diet. Mice were genotyped by Southern blotting of ear DNA digested with XbaI, as described previously (Delibegovic et al. 2003) .
Immunological techniques
Unless indicated otherwise, 20 mg protein lysates were subjected to SDS-PAGE (Novex, Invitrogen) and transferred to nitrocellulose membranes. The membranes were incubated with affinity purified antibody at 1 mg/ml or at dilutions recommended by the suppliers in 50 mM Tris-HCl (pH 7 . 5), 0 . 15 M NaCl, 0 . 1% (v/v) Tween-20 containing 5% (w/v) skimmed milk for 16 h at 4 8C. Detection was performed using horseradish peroxidase-conjugated secondary antibodies and enhanced chemiluminescence or fluorescently labelled secondary antibodies and analysis using a Li-Cor Odyssey infrared detection system following the manufacturer's guidelines (Li-Cor, Cambridge, UK). The band intensity was quantified using Li-Cor software.
Antibodies to G M , PP1a and PP1b, have been described previously (Delibegovic et al. 2003) . Antibodies to humanPP2A C a/b (289-FDPAPRRGEPHVTRRTPDY-307) and the PH domain of protein kinase B (PKB) were raised in sheep by Diagnostics Scotland (Penicuik, Midlothian, UK) and affinity purified by the Division of Signal Transduction Therapy, University of Dundee, co-ordinated by Dr Hilary McLauchlan and Dr James Hastie. Peptides were synthesised by Dr G Bloomberg (University of Bristol, UK). Antibodies to phosphorylase kinase purified from rabbit skeletal muscle (Cohen 1983) were similarly raised in sheep and the immunoglobulin G (IgG) was isolated using protein G-Sepharose. Antibodies to rat AMP-activated protein kinase (AMPK) a1 (344-CTSPPDSFLDDHHLTR-358), AMPKa2 (352-CMDDSAMHIPPGLKPH-366) and AMPK phospho-Thr172 were supplied by Prof. D G Hardie (University of Dundee). Antibodies against PKB (phospho-Thr308), PKBa/PKBb (phospho-Ser473), GSK3a/GSKb (phospho-Ser 21/9), acetyl-CoA carboxylase (ACC) and ACC phospho-Ser212 were from Cell Technology (Hitchin, UK). Other antibodies employed were: anti-GSK3a/GSK3b (Biosource, Nivelles, Belgium), anti-GLUT4 from clone 1F8 ( (James et al. 1988) , Biogenesis, Poole, UK) and anti-GLUT4 C-terminal 15 amino acids (Abcam, Cambridge, UK). For analysis of GLUT4, the anti-GLUT4 C-terminal antibody (Abcam) was covalently coupled to protein G-Sepharose beads and incubated with skeletal muscle lysates overnight at 4 8C. The 10 000 g immunopellets were washed three times and examined by sodium dodecyl gel electrophoresis followed by immunoblotting with anti-GLUT4 antibodies. Immunoblot analysis of ACC was performed according to Sakamoto et al. (2005) , except that lysates were prepared with the addition of 1 mM microcystin.
Glucose and insulin tolerance testing
Blood glucose levels were assessed using the AccuChek Blood Glucose Monitoring System (Roche Diagnostics). Glucose tolerance tests were performed on mice after a 12-14 h overnight fast. Mice were injected intraperitoneally with 2 mg D-glucose/g, and blood glucose levels were determined immediately before and at 15, 30, 60 and 120 min following injection. Insulin tolerance was assessed by measuring blood glucose levels before and 15, 30, 60 and 120 min after mice had received an i.p. injection of 1 mU/g insulin (Human Actrapid, 100 iU/ml; Novo Nordisk Pharmaceuticals Ltd, Crawley, UK) after a 6-h fast. In vivo glucose transport was determined after i.p. injection of 2-deoxy-D- [1, [2] [3] H]-glucose mixed with 20% dextrose (2 g/kg body weight; 10 mCi/mouse) according to Zisman et al. (2000) .
Measurement of serum parameters
Blood samples were measured using the AccuChek Blood Glucose Monitoring System. Up to 100 ml blood was collected from mice after an overnight fast and serum stored at K80 8C. Serum triglycerides and free fatty acids were measured using the commercially available kits (Biostat, Stockport, UK; Wako Diagnostic Systems, Neuss, Germany). Serum insulin was measured by ELISA assay (Crystal Chem Inc., Downers Grove, IL, USA).
Preparation of tissue lysates and subcellular fractions
After an overnight fast, mice were killed by concussion followed by cervical dislocation, and tissues were rapidly extracted and freeze clamped in liquid nitrogen before being stored at K80 8C. Tissues were ground to a fine powder under liquid nitrogen. Skeletal muscle was obtained from whole hind limbs unless otherwise stated and ground under liquid nitrogen. The pulverised tissues were homogenised in 10 vol/g ice-cold 50 mM Tris-HCl (pH 7 . 5), 150 mM NaCl, 2 mM EGTA, 2 mM EDTA, 5% (v/v) glycerol, 0 . 1% (v/v) 2-mercaptoethanol, 'complete' protease inhibitor cocktail (Buffer A) plus 0 . 1% (v/v) Triton X-100 and 1 mM microcystin-LR (Life Technologies), using a Polytron PT-1200 and centrifuged at 16 000 g for 10 min at 4 8C. The supernatant (lysate) was snap-frozen in liquid nitrogen and stored at K80 8C.
For phosphorylase kinase assays, mice were terminally anaesthetised for 20 min by an i.p. injection of 60 mg/g pentobarbital followed by a further injection of 40 mg/g propranolol to inhibit the effects of adrenaline. Skeletal muscle was harvested 30-90 min after propranolol administration and homogenised in 10 vol/g ice-cold 50 mM Tris-HCl (pH 7 . 5), 2 mM EDTA, 20 mM EGTA, 1 mM sodium orthovanadate, 50 mM NaF, 5 mM pyrophosphate, 0 . 1% (v/v) Triton X-100, 1 mM microcystin-LR, 0 . 1% (v/v) 2-mercaptoethanol and 'complete' protease inhibitor cocktail.
For preparation of membrane and cytosolic fractions, frozen ground skeletal muscle was homogenised in 4-6 vol/g buffer A. The homogenates were centrifuged at 1000 g for 10 min at 4 8C to remove nuclei, and the supernatant was centrifuged at 100 000 g for 1 h at 4 8C. The 100 000 g supernatant (termed cytoplasmic fraction) was snap-frozen and stored at K80 8C. The pellet (termed membrane fraction) was washed twice in ice-cold Buffer A with repeated centrifugation at 100 000 g for 30 min, and finally resuspended in 300 ml ice-cold buffer A containing 1% Triton X-100. This lysate was snapfrozen and stored at K80 8C.
Enzyme assays and glycogen content
Phosphorylase kinase was assayed using the peptide KRKQISVRGLA (residues 10-20 of human muscle phosphorylase b) as a substrate. Skeletal muscle lysate (50-100 mg) diluted in 100 ml 50 mM Tris-HCl (pH 7 . 5), 150 mM NaCl, 0 . 1% (v/v) 2-mercaptoethanol, 'complete' protease inhibitor cocktail was incubated for 1 h at 4 8C on a shaking platform with 30 mg anti-PhK antibody non-covalently coupled to 10 ml protein G-Sepharose. Following centrifugation for 1 min at 16 000 g, the pellets were washed twice with 0 . 5 ml 50 mM Tris-HCl (pH 7 . 5), 500 mM NaCl, 0 . 1% (v/v) 2-mercaptoethanol and once with 50 mM Tris-HCl (pH 7 . 5), 0 . 1% (v/v) 2-mercaptoethanol. The pellet was assayed for PhK activity in 50 ml 50 mM Tris-HCl, 50 mM sodium-2-glycerophosphate pH 8 . 6 or pH 6 . 8, 2 . 5 mM cyclic-AMP-dependent protein kinase inhibitor (TT YADFIASGRTGRRNAIHD), 10 mM magnesium acetate, 100 nM okadaic acid, 0 . 1% (v/v) 2-mercaptoethanol, 0 . 1 mM [g-32 P]ATP, 0 . 5 mg/ml (w400 mM) phosphorylase b peptide and 0 . 04 mM CaCl 2 . Assays were performed for 20 min at 30 8C with constant agitation and were terminated by spotting 40 ml onto Whatman P81 paper, followed by immersion in 75 mM phosphoric acid. Papers were washed for 4! 15 min in 75 mM phosphoric acid, once briefly in water and then acetone. 32 P incorporation was determined by Cerenkov counting on a liquid scintillation counter. One unit (U) of kinase activity is defined as that which catalyses the incorporation of 1 mmole of 32 P into substrate peptide per minute.
AMPKa1 and a2 activities were assayed by Ser phosphorylation of the peptide substrate AMARAA-SAAALARRR following isoform-specific immunoadsorption (Sakamoto et al. 2005) . Glycogen was measured using the anthrone reagent after extraction from skeletal muscle with 1 mol/l NaOH at 100 8C for 60 min (Roe & Dailey 1966) .
Statistical analysis
All data are presented as meanGS.E.M. Statistical significance was tested using Student's t-test, except where stated otherwise.
Results
Phenotypic analysis of G K=K M mice backcrossed more than six times onto C57BL/6 and 129s2/sV backgrounds The G K=K M mice that developed obesity, glucose intolerance and insulin resistance in late adult life (Delibegovic et al. 2003) and lean, glucose-tolerant, insulin-sensitive G K=K M mice of Suzuki et al. (2001) were created using 129/ Ola and 129/SvJ mouse embryonic stem cells respectively, backcrossed to the C57BL/6 strain and examined after two to three backcrosses. Extensive genetic variability among 129 substrains has been reported (Simpson et al. 1997) . Although129/Ola and 129/SvJ are from the same parental lineage, they were separated by a contamination introduced into the Sv and SvJ lines. However, examination of 25 protein markers did not uncover any variation between 129/Ola-Hsd and 129/ SvJ at the protein level (Simpson et al. 1997) . In order to determine whether the different phenotypes of the G K=K M mouse models reside in the different genetic backgrounds of the 129 substrains used to create them, the obese, glucose-intolerant, insulin-resistant G K=K M mice of Delibegovic et al. (2003) were further backcrossed onto a C57BL/6 background. After at least six backcrosses, the mice, as expected, had no G M protein in skeletal muscle detectable by immunoblotting and low PP1b levels (Fig. 1A) as observed previously for G 129/Ola mice breed poorly and were not available for backcrossing. We therefore crossed the obese G K=K M mice onto a related 129s2/sV background. After more than six backcrosses, the 129s2/sV G K=K M mice showed no increase in body weight or abdominal fat compared with 129s2/sV G C=C M mice up to 12 months of age (Fig. 1E) . Glucose tolerance and insulin sensitivity in mice of more than 12 months of age was similar to that of controls ( Fig. 1F and G) . No significant differences in fasting blood glucose levels were observed in lean C57BL/6 G suggesting that triglyceride increase may contribute to the development of obesity in these mice during the early stages. Serum-free fatty acids and serum insulin levels of lean C57BL/6 G K=K M mice showed a tendency towards lower and higher levels respectively than controls, but the differences were not statistically significant.
Analysis of the effects of environmental factors on lean C57BL/6 G K=K
M mice
Environmental factors such as the composition of the diet and total food intake could also underlie the differences between the two models of G K=K M mice. However, the food intake of lean C57BL/6 G K=K M mice was similar to that of C57BL/6 G C=C M controls (data not shown) and previous studies showed that the food intake of obese G K=K M mice was similar to the food intake of control mice (Delibegovic et al. 2003) . Since the G K=K M mice are defective in the conversion of glucose to glycogen in skeletal muscle, we examined the effects of increasing glucose levels in the diets. After addition of 30% glucose to the diet of lean C57BL/6 G K=K M and control C57BL/6 G C=C M mice from weaning to 6 months of age followed by a diet of standard chow, glucose tolerance of the G K=K M mice was not significantly different from that of the controls at 8 ( Fig. 2A) and 12 months of age (Fig. 2B) . Insulin sensitivity in the C57BL/6 G K=K M and control mice was similar at 12 months of age (data not shown). A high-protein, lowcarbohydrate diet also did not modulate glucose tolerance or insulin resistance (data not shown). (Fig. 3B, right  panel) . The use of propranolol prevented inadvertent activation of PhK in response to adrenalin, because the latter may take up to 90 min to decline to zero (Toole & Cohen 2007) . In contrast to the pH 6 . 8 activity, the PhK activity at pH 8 . 6, which is a measure of the total activity, was similar in lean C57BL/6 G K=K M and control mice.
Activation of PhK at pH 6 . 8 has been linked with phosphorylation of the enzyme (Krebs 1972 ) and correlated with phosphorylation of a specific serine in a peptide of the b-subunit of PhK (Stewart et al. 1981) , identified as Ser26 (Kilimann et al. 1988) . Our data therefore imply that the b-subunit is hyperphosphorylated on Ser26 and are consistent with PhK being an in vivo substrate of PP1-G M . The pH 6 . 8/8 . 6 activity was 0 . 53 and 0 . 19 for lean C57BL/6 G K=K M and control mice respectively.
The insulin-sensitive kinase cascade leading to the activation of GS was functional in the skeletal muscle of lean C57BL/6 G K=K M mice (Fig. 3C ) similarly to obese G K=K M mice (Delibegovic et al. 2003) . PKB is activated in response to insulin by phosphorylation on Thr308, which in turn inhibits GSK3a and GSK3b by phosphorylation of Ser21 and Ser 9 respectively. PKB, GSK3a and GSK3b were phosphorylated similarly to controls in the skeletal muscle of lean C57BL/6 G K=K M mice in response to insulin (Fig. 3C) ; GSK3a and GSK3b also responded similarly to insulin in the skeletal muscle of obese G K=K M and control mice (Delibegovic et al. 2003) .
Since energy derived from glycogen is decreased in G K=K M mice, we analysed AMPK, which is a sensor of cellular energy . The activity of the AMPKa1 isoform was similar in the skeletal muscle of C57BL/6 G C=C M , lean C57BL/6 G K=K M and obese G K=K M mice, but the activity of the AMPKa2 isoform was more than threefold higher in lean C57BL/6 G K=K M mice than in controls (Fig. 4A ) and twofold higher in obese G K=K M mice than in controls (data not shown). Consistent with the increase in AMPKa2 activity, phosphorylation of Thr172 in AMPKa2 was increased, while no increase in phosphorylation of AMPKa1 was observed (Fig. 4B) . The level of total AMPK (both a1Ca2) was similar in all lines as judged by immunoblotting. A downstream target of AMPK is acetyl-CoA carboxylase (ACC) that can be activated by phosphorylation. The levels of ACC in mouse skeletal muscle were extremely low as judged by immunoblotting, but there was no clear increase in phosphorylation of ACC Ser212 in the total hind limb muscle of lean C57BL/6 G K=K M mice compared with controls (data not shown) or in the gastrocnemius muscle, which had slightly higher levels of ACC (Fig. 4C ). Blood samples were obtained from the tail veins of mice aged 6 -8 months.
The values for G K=K M versus G C=C M mice were not significantly different using Student's t-test for any component. The numbers of mice tested are given in brackets. NEFA denotes non-esterified fatty acids. The fasting serum insulin levels were also not significantly different when assessed using the Mann-Whitney-Wilcoxon U test. Figure 2 Glucose tolerance tests performed on male C57BL/ 6 mice born after at least six backcrosses and fed a diet containing 30% extra glucose from weaning to 6 months, then a standard chow diet for either 2 months (A) or 6 months (B). Results are meanGS.E.M. for 11 G (Fig. 5) . Since AMPK may modulate glucose transport through the insulin-stimulated glucose transporter GLUT4, we analysed GLUT4 and hexokinase II (HKII), which catalyses conversion of the intracellular glucose to glucose-6-phosphate in skeletal muscle. No change in the level of HKII was observed in lean C57BL/6 G K=K M compared with C57BL/6 G C=C M mice (Fig. 6A) . Of three commercial anti-GLUT4 antibodies, no two antibodies recognised the same 40-50 kDa band in mouse skeletal muscle lysates (prepared in the presence of the detergent Triton X-100 to solubilise GLUT4). Membrane fractions, which would be expected to contain GLUT4, were then prepared and GLUT4 was again released using Triton X-100. Following immunoadsorption of GLUT4 from the lysates (Fig. 6B ) or membrane fractions (Fig. 6C) with an antibody raised to the 15 C-terminal amino acids of GLUT4 (Abcam), a 46 kDa band could be recognised by the same antibody and also by a monoclonal antibody 1F8 raised against partially purified GLUT4-containing vesicles (Biogenesis; Fig. 6C ). The precise 1F8 antibody epitope is not known but it lies in the cytoplasmic portion of GLUT4 (James et al. 1988 , Imamura et al. 2001 . The 46 kDa protein was present in the membrane fraction and not in the cytosolic fraction as might be expected for GLUT4. Although immunoblotting of the immunopellets resulted in some variation between samples, there was no clear difference in the levels of GLUT4 in the membrane fractions from whole hind limb muscles, the quadriceps muscle or the gastrocnemius muscle of lean C57BL/6 G K=K M mice compared with G C=C M controls (Fig. 6C ).
Discussion
Our studies show that continued backcrossing of the obese, glucose-intolerant, insulin-resistant G K=K M mice onto two different genetic backgrounds gave rise to lean, glucose-tolerant, insulin-sensitive G K=K M mice. The loss of the prediabetic phenotype suggests that at least one further variant gene in the 129/Ola background, not present in the C57BL/6 or 129s2/sV background, may be required for the development of the prediabetic G K=K M phenotype. This situation is similar to the interaction of two variant genes underlying severe insulin resistance in the human population (Savage et al. 2002) . Environmental changes, including a highfat diet (Suzuki et al. 2001 ) and high-carbohydrate diet (this study) fed to lean G K=K M mice, were insufficient to lead to glucose intolerance and insulin resistance, despite the severely decreased ability of lean G K=K M mice to convert glucose to glycogen in skeletal muscle. However, interestingly, mice completely devoid of glycogen in skeletal muscle due to disruption of the muscle GS gene exhibit either normal or improved glucose tolerance (Pederson et al. 2005a) . It has been suggested that the reason may be because, in contrast to Figure 4 (A) Activities of AMPKa1 and AMPKa2 isoforms in skeletal muscle lysates from five C57BL/6 G humans who rely on skeletal muscle glycogen for muscle contraction, rodents may be more dependent on liver glycogen stores (Baldwin et al. 1973 , Pederson et al. 2005b ).
An alternative or additional explanation to the requirement of further variant gene(s) in G K=K M mice for the development of insulin resistance is that further backcrossing may lead to compensatory changes that ameliorate the prediabetic phenotype. A comparison of the C57BL/6 G K=K M mice analysed in this manuscript compared with those in previous studies is presented in Table 2 . The glycogen level in the skeletal muscle of the lean C57BL/6 G K=K M mice was higher (30% of controls) than in the obese G K=K M mice (10% of controls), but this is unlikely to account for the difference between the lean and obese models because the G H]-glucose tracer and unlabelled glucose was injected into six G disruption of the G M gene may be expected to lead to decreased ATP production from glycogen and consequent elevation of AMP, leading to the activation of AMPK, which is a sensor of cellular energy levels and has also been proposed to be a sensor of glycogen stores (Hardie & Sakamoto 2006) . One of the downstream actions of AMPK is to phosphorylate and inhibit ACC 2 in skeletal muscle, decreasing the production of malonyl-CoA, an allosteric inhibitor of carnitine palmitoyltransferase 1. Since the latter enzyme is rate limiting for the entry of long-chain fatty acyl-CoA into the mitochondria for oxidation, relief from inhibition leads to an increase in the oxidation of fatty acids (Saha & Ruderman 2003 . Although this mechanism is attractive for allowing fatty acids to be used as an alternative energy source to glycogen in G AMPK also increases the expression of the insulinstimulated glucose transporter GLUT4, which is highly regulated by a number of factors (Zorzano et al. 2005) . Nevertheless, following immunoadsorption and centrifugation, immunoblotting of the pellets yielded no clear differences in level of GLUT4 in lysates or membrane fractions of skeletal muscle from fasted lean C57BL/6 G K=K M mice compared with G C=C M controls. The approximately threefold rise in AMPK activity therefore also appears to be insufficient to elicit a detectable change in the expression level of GLUT4 in the basal state.
Normally, in the basal state, GLUT4 is excluded from the plasma membrane and resides in the endosomal system and specialised intracellular vesicles termed GLUT4 storage vesicles (Shepherd & Kahn 1999 , Welsh et al. 2005 . The addition of insulin results in translocation of GLUT4 to the plasma membrane and 10-to 20-fold increases in GLUT4 levels at the plasma membrane (sarcolemma and T-tubule) are observed after insulin stimulation. Alterations in GLUT4 localisation that enhance glucose uptake are observed not only in response to insulin but also during exercise and muscle contraction, although the mechanisms and pathways are not fully defined (Jessen & Goodyear 2005) . AMPK has been implicated in the translocation of GLUT4 in response to exercise and contraction (Merrill et al. 1997 , Hayashi et al. 1998 , Mu et al. 2001 alleles. Although we cannot exclude an additional alteration closely linked to the G M gene, such a mutation would have to be very closely linked to the original G M disruption, but probably not in the adjacent genes since it was eliminated by six to ten backcrosses. In addition, the mutation would have to give rise to glucose intolerance, insulin resistance and obesity, since G C=C M littermates of the obese G K=K M mice did not develop the prediabetic phenotype. Genetic interaction of G M with a gene in the 129/Ola background would therefore appear more likely. Elevated triglycerides were observed in the blood plasma of 2-5 month obese G K=K M mice suggesting that a plausible mechanism underlying the development of glucose intolerance in these mice is that the higher lipid levels may lead to obesity and substantially decrease the transport of glucose into the skeletal muscle. Decreased glucose transport may underlie the insulin resistance phenotype, but it should be noted that obesity and insulin resistance are not always linked (Uysal et al. 2000) . The influence of the genetic background on the phenotype of gene knockout models has been noted in other instances. For example, depending on the genetic background, insulin receptor substrate 2 knockout mice may die due to a combination of impaired insulin action and insulin deficiency on a C57BL/6!129/Sv background (Withers et al. 1998) or develop diabetes with no insulin deficiency on a C57BL/6!CBA background (Kubota et al. 2000) .
In vitro analyses predicted that phosphorylase, PhK and GS are substrates of PP1-G M . Biochemical analyses of G K=K M mice have shown that in the fasted state phosphorylase is hyperphosphorylated on Ser14 with increase of activity, while GS is hyperphosphorylated on Ser640 and Ser644 with decrease in activity compared with controls, confirming that these enzymes are in vivo substrates of PP1-G M (Table 2) . From in vitro studies, it was observed that PhK is a better substrate for PP1 than it is for PP2A, PP2B/calcineurin or the Mg2+-dependent protein phosphatases (PPM1/PP2C) (Ingebritsen & Cohen 1983) and it can be inactivated by PP1-G M in vitro (Hubbard & Cohen 1989 ). In addition, both PhK and PP1-G M are bound to glycogen.
The pH 6 . 8/pH 8 . 6 activity ratios presented here indicate that PhK is hyperphosphorylated on its regulatory b-subunit in the basal state, demonstrating for the fist time that PhK is an in vivo substrate of PP1-G M . The only other enzyme that we found to be hyperphosphorylated with alteration of activity was AMPKa2, but there is no in vitro data linking PP1-G M with dephosphorylation of AMPK. The low level of activation and phosphorylation of AMPKa2 in G K=K M mice also support the concept that this alteration is likely to arise as a secondary event, possibly as a consequence of lower cellular energy in the presence of low levels of glycogen.
